NCT03871621View on ClinicalTrials.gov

Left Ventricular Functional Changes of Uncontrolled Diabetes by Dapagliflozin Treatment Trial

PHASE4CompletedINTERVENTIONAL
Enrollment

76

Participants

Timeline

Start Date

April 1, 2019

Primary Completion Date

May 1, 2022

Study Completion Date

August 31, 2022

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

Diabetes Medicines

Anti-diabetic medications except SGLT2 inhibitors

DRUG

Dapagliflozin

Dapagliflozin tablet (10 mg)

Trial Locations (1)

Unknown

Mackay Memorial Hospital, Taipei

All Listed Sponsors
lead

Mackay Memorial Hospital

OTHER

NCT03871621 - Left Ventricular Functional Changes of Uncontrolled Diabetes by Dapagliflozin Treatment Trial | Biotech Hunter | Biotech Hunter